Delivery Order SPE2DB24D2010-SPE2DB24FZXN3

Award Date 8/29/24
Potential Completion Date 8/30/24
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of COSENTYX SENSOREADY 150 MG PENML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $18,986.58, is a firm fixed-price delivery order with an ultimate completion date of January 14, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not designated as a set-aside. Amerisourcebergen also holds a $999,999,999...
This federal contract award is for the delivery of COSENTYX SENSOREADY 150 MG PENML medical supplies to the Defense Logistics Agency (DLA). The contract, valued at $10,515.98, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a delivery order, with a firm fixed price pricing type, and an ultimate completion date of February 21, 2025. The contract does not have a set-aside designation, indicating...
This federal contract award is for the delivery of the pharmaceutical product "COSENTYX SENSOREADY 150 MG PENML" to the Defense Logistics Agency (DLA). The $5,283.56 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 4, 2024, with a completion date of December 5, 2024. The contract is a delivery order and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $16,787.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of COSENTYX SENSOREADY 150 MG PENML, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of November 22, 2023. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of COSENTYX SENSOREADY 150 MG PENML medical products. The award, valued at $27,363.42, is a firm fixed price delivery order contract with the Defense Logistics Agency (DLA). The contract has an ultimate completion date of January 29, 2025 and was awarded on January 28, 2025. This contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of COSENTYX SENSOREADY 150 MG PEN medication. The contract, valued at $2,392.79, is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency within the Department of Defense. The contract has a firm fixed-price pricing type and an ultimate completion date of November 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $14,136.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the provision of COSENTYX SENSOREADY 150 MG PENML, a pharmaceutical product. The contract has an ultimate completion date of April 28, 2025 and is a firm fixed-price contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This contract award is for delivery orders of COSENTYX SENSOREADY 150 MG PENML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $11,460.04. The contract is a firm-fixed-price delivery order contract with an ultimate completion date of January 13, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $18,183.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of COSENTYX SENSOREADY 150 MG PENML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of December 20, 2024. This contract award is associated with a larger Indefinite Delivery Contract...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of COSENTYX SENSOREADY 150 MG PENML medication. The award, valued at $7,493.34, was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, through a Delivery Order contract with a Firm Fixed Price pricing type. The contract has an ultimate completion date of November 25, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB24FZXN3
    Delivery Order

This federal contract award is for the supply of COSENTYX SENSOREADY 150 MG PENML pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $3,114.84 and is a delivery order, with a firm fixed-price pricing type. The contract does not have a set-aside designation and has an ultimate completion date of August 30, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, for providing a wide range of pharmaceutical and medical supplies to support military treatment programs and federal healthcare needs.

Generated 11/28/24, 9:09 AM